Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 114 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Doumas, Michael  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Imprialos, K. P., Boutari C., Stavropoulos K., Doumas M., & Karagiannis A. I. (2017).  Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?. J Neurol Neurosurg Psychiatry. 88(3), 249-253.
Stavropoulos, K., Imprialos K. P., Doumas M., Athyros V. G., & Karagiannis A. (2018).  Subclinical target organ damage in primary aldosteronism: resistant to spironolactone therapy?. J Hypertens. 36(3), 701.
Douma, S., Petidis K., Kamparoudis A., Gkaliagkousi E., Anyfanti P., Doumas M., et al. (2012).  Surgical management of primary aldosteronism. not everything that shines is gold.. Clin Exp Hypertens. 34(1), 53-6.
T
Doumas, M., & Papademetriou V. (2009).  Telmisartan for prevention of cardiovascular events.. N Engl J Med. 360(3), 302; author reply 303.
Stavropoulos, K., Imprialos K. P., & Doumas M. (2017).  Testosterone Replacement Therapy and Cardiovascular Risk-A Closer Look at Additional Parameters.. JAMA Intern Med. 177(9), 1393.
Patoulias, D., Katsimardou A., Kalogirou M-S., Karagiannis A., & Doumas M. (2019).  Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?. Dig Liver Dis.
Doumas, M., Tsioufis C., Fletcher R., Amdur R., Faselis C., & Papademetriou V. (2017).  Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension.. J Am Heart Assoc. 6(11), 
Chrysanthopoulou, A., Mitroulis I., Kambas K., Skendros P., Kourtzelis I., Vradelis S., et al. (2011).  Tissue factor-thrombin signaling enhances the fibrotic activity of myofibroblasts in systemic sclerosis through up-regulation of endothelin receptor A.. Arthritis Rheum. 63(11), 3586-97.
Doumas, M., Athyros V., & Karagiannis A. (2015).  Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?. Cardiology. 131(3), 186-8.
Papademetriou, V., & Doumas M. (2009).  Treatment strategies to prevent stroke: focus on optimal lipid and blood pressure control.. Expert Opin Pharmacother. 10(6), 955-66.
U
Manolis, A., Doumas M., Poulimenos L., Kallistratos M., & Mancia G. (2013).  The unappreciated importance of blood pressure in recent and older atrial fibrillation trials.. J Hypertens. 31(11), 2109-17; discussion 2117.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 71, 17 - 32.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.
W
Stavropoulos, K., Imprialos K., Doumas M., & Athyros V. G. (2018).  What is the role of statins in the elderly population?. Expert Rev Clin Pharmacol. 11(4), 329-331.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές